The event is free and open to the public

Chestnut Hill College will celebrate its
26th Annual Biomedical Distinguished Lecture Series
on Wednesday, April 10 with a presentation on the difficulties of treating
pancreatic cancer by Jonathan Brody, Ph.D. The event begins at 2 p.m. in
the East Parlor of St. Joseph Hall and is free and open to the public.

Dr. Jonathan Brody is the director of surgical research and co-director of
the Jefferson Pancreatic, Biliary and Related Cancer Center. He is also a
member of the Kimmel Center and a professor within Chestnut Hill College’s
surgery and pathology departments. His lab focuses on the many molecular
aspects of pancreatic cancer, including how to target a novel pro-survival
network in pancreatic cancer cells and optimize current therapies used in
the clinic. He has published more than 100 peer-review publications in many
top-tier scientific and cancer journals, and he has an interest in
personalizing therapy for pancreatic cancer patients.

Brody received his Ph.D. from Johns Hopkins University School of Medicine,
and his thesis specialized in studying the molecular aspects of cancer and
cancer genetics. He patented, along with Dr. Scott Kern, novel buffers for
DNA identification that have changed the format of this molecular biology
technique that is used to detect DNA. He was elected chair of the Cancer
Research Program, Department of Defense Council, and he serves on many
international study sections, including being the chair of the tumor
biology and genomics study section for the American Cancer Society and NCI
study section panels. Additionally, he was an American Cancer Society
Research Scholar, and he is NIH funded and the winner of the 2010 American
Association of Cancer Research’s Pancreatic Cancer Career Development
Award.